Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1371-1378, July 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogler, W. R.
Right arrow Articles by Groth, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogler, W. R.
Right arrow Articles by Groth, D. P.

Studies on the Effects of Hydroxyurea and Other Anticancer Drugs upon Pyrimidine Metabolism1

William Ralph Vogler, Susan Horwitz2 and D. P. Groth

Department of Medicine (Division of Hematology), School of Medicine, and Departments of Pharmacology and Biochemistry, Division of Basic Health Sciences, Emory University, Atlanta, Georgia 30322

The reversal of azauridine-induced oroticaciduria by hydroxyurea has been studied to further elucidate the control mechanisms involved in the de novo pathways of pyrimidine biosynthesis. No direct effect of hydroxyurea upon partially purified aspartate transcarbamylase and dihydroorotase was observed. Hydroxyurea selectively inhibited the incorporation of 14C-labeled aspartate, orotate, and formate into the DNA bases of human leukemic cells incubated in vitro. No effect of hydroxyurea was observed in the RNA bases isolated from these leukemic cells. Other chemotherapeutic agents, including 5-iododeoxyuridine, 5-fluorodeoxyuridine, Methotrexate, cytosine arabinoside, and cyclophosphamide, were administered to patients receiving 6-azauridine. Only Methotrexate and cyclophosphamide inhibited orotic acid excretion in a manner similar to hydroxyurea. These results suggest that the control of pyrimidine biosynthesis is linked to DNA synthesis or function in an as yet unexplained manner.

1 This investigation was supported by USPHS Research Grants CA-05733 and CA-03528 from the National Cancer Institute and FR-39 from the General Clinical Research Centers Branch, Division of Research Facilities and Resources.

2 Present Address: Department of Medicine, Albert Einstein School of Medicine, New York, New York.

Received 8/12/68. Accepted 2/13/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.